118 related articles for article (PubMed ID: 8972234)
1. Evaluation of the developmental toxicity of theophylline, dimethyluric acid, and methylxanthine metabolites using Xenopus.
Fort DJ; Stover EL; Propst T; Hull MA; Bantle JA
Drug Chem Toxicol; 1996 Nov; 19(4):267-78. PubMed ID: 8972234
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the developmental toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX.
Fort DJ; Stover EL; Propst T; Hull MA; Bantle JA
Drug Chem Toxicol; 1998 Feb; 21(1):15-26. PubMed ID: 9530527
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ
Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the developmental toxicity of benzo[a]pyrene and 2-acetylaminofluorene using Xenopus: modes of biotransformation. Stover Group.
Propst TL; Fort DJ; Stover EL; Schrock B; Bantle JA
Drug Chem Toxicol; 1997; 20(1-2):45-61. PubMed ID: 9183562
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of acetaminophen-induced developmental toxicity using FETAX.
Fort DJ; Rayburn JR; Bantle JA
Drug Chem Toxicol; 1992; 15(4):329-50. PubMed ID: 1459044
[TBL] [Abstract][Full Text] [Related]
6. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
Fort DJ; Bantle JA
Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxic convulsions induced by theophylline and its metabolites in mice.
Yamamoto K; Toyama E; Kawakami J; Sawada Y; Iga T
Biol Pharm Bull; 1996 Jun; 19(6):869-72. PubMed ID: 8799489
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay--Xenopus: possible mechanisms of action.
Fort DJ; Propst TL; Stover EL
Teratog Carcinog Mutagen; 1996; 16(6):307-15. PubMed ID: 9178453
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
Fort DJ; Stover EL; Bantle JA; Finch RA
Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus.
Fort DJ; Stover EL; Rayburn JR; Hull M; Bantle JA
Teratog Carcinog Mutagen; 1993; 13(1):35-45. PubMed ID: 8100651
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX.
Fort DJ; McLaughlin DW; Rogers RL; Buzzard BO
Drug Chem Toxicol; 2003 Feb; 26(1):23-34. PubMed ID: 12643038
[TBL] [Abstract][Full Text] [Related]
12. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
Fort DJ; Rogers RL; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
[TBL] [Abstract][Full Text] [Related]
13. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
Fort DJ; Stover EL; Farmer DR; Lemen JK
Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.
Ramzan IM; Levy G
J Pharmacol Exp Ther; 1986 Mar; 236(3):708-13. PubMed ID: 3485196
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Bantle JA
Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
[TBL] [Abstract][Full Text] [Related]
16. Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX.
Fort DJ; Rayburn JR; DeYoung DJ; Bantle JA
Drug Chem Toxicol; 1991; 14(1-2):143-60. PubMed ID: 1889373
[TBL] [Abstract][Full Text] [Related]
17. Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation.
Fort DJ; Rogers RL; Paul RR; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):117-27. PubMed ID: 11360430
[TBL] [Abstract][Full Text] [Related]
18. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.
Monks TJ; Caldwell J; Smith RL
Clin Pharmacol Ther; 1979 Oct; 26(4):513-24. PubMed ID: 487699
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of water disinfection by-products, bromochloroacetic and dibromoacetic acids, on frog embryogenesis.
Weber N; Higuchi T; Tessari J; Veeramachaneni DN
J Toxicol Environ Health A; 2004 Jun; 67(12):929-39. PubMed ID: 15205036
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of theophylline and its inhibition by fluoroquinolones in rat hepatic microsomes.
Davis JD; Aarons L; Houston JB
Xenobiotica; 1995 Jun; 25(6):563-73. PubMed ID: 7483657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
